The FDA has approved a new premixed version of heparin, a well-known blood thinner, packaged in a plastic container for intravenous use. Heparin helps stop blood from clotting. Doctors use it to prevent and treat serious clots in the veins and lungs, to lower clot risk in people with an irregular heartbeat called atrial fibrillation, and to prevent clotting during heart surgery, dialysis, and blood transfusions.
This form is for hospital and clinic settings, where it is given through a vein. It is not a pill and not for home use. The approval gives health care teams a ready-to-use option, which can save time and reduce the chance of mixing errors.
The label says dosing must be adjusted based on blood test results, and that platelet counts and other tests should be checked during treatment. It also warns that the product is for intravenous infusion only, must not be used to flush catheters, and should not be mixed with other drugs.
One honest caveat: this news does not mean patients should ask for or change any blood thinner on their own. If you have questions about heparin or clot treatment, talk with your doctor.
